filmov
tv
Cereblon modulators: a new class of myeloma therapy — Dr. Sagar Lonial | MCRT Webcast August 22
Показать описание
HealthTree Foundation for Multiple Myeloma
multiple myeloma
myeloma crowd
myeloma
cancer
myeloma treatment
Рекомендации по теме
0:12:22
Cereblon modulators: a new class of myeloma therapy — Dr. Sagar Lonial | MCRT Webcast August 22
0:03:16
What is cereblon and how is it related to IMIDs?
0:00:42
What is cereblon?
0:02:25
What is a CELMoD?
0:40:18
Cereblon (CRBN), Common Target of Multiple Pharmacological Actions of Thalidomide and Derivatives
0:05:43
What is a CELMoD? How is it different from and IMiD?
2:13:00
Cereblon enhancer methylation and IMiD resistance in multiple myeloma
0:39:11
Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Ot...
0:39:11
Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting ...
0:00:55
Immune-Mediated Inflammatory Disease (I.M.I.D.) | Metabolic Mentor Education #immunehealth
0:02:28
Game-changing drug classes for multiple myeloma
0:02:31
Benefits of CELMoDs over IMiDs in multiple myeloma
0:07:08
Genomic Studies to Identify Mechanisms of Resistance to IMiDs Drugs in Multiple Myeloma
0:37:46
Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD
0:01:59
The growing importance of CELMoDs in the treatment of R/R multiple myeloma
0:06:32
CC-92480: a novel CELMoD, in R/R myeloma
0:19:06
New paradigms/therapies in relapsed/refractory myeloma: Small molecules & monoclonal antibodies
0:01:55
Recent updates on CELMoDs in multiple myeloma
0:11:57
Myeloma Round Table Immunotherapy, Checkpoint Inhibitors and Combination Approaches
0:09:34
Treatment for Relapsed/Refractory Multiple Myeloma
0:10:13
Immunomodulatory Drugs and DDB1-CRBN E3 Ubiquitin Ligase in virtual reality
0:58:19
Sequencing BCMA Myeloma Therapies
0:02:33
Immunomodulatory drugs
0:02:40
First in class targeted drug daratumumab shows promise in MM